Home › GSK readies 'bubble boy' drug as big pharma bets on gene therapy
 

Keywords :   


GSK readies 'bubble boy' drug as big pharma bets on gene therapy

2015-04-27 19:30:48| Biotech - Topix.net

GlaxoSmithKline is close to seeking European approval for a gene therapy drug to fight adenosine deaminase severe combined immune deficiency in the latest sign of a renaissance in the technology to fix faulty genes. A uniQure bioprocessing engineer checks a monitor of a sterile disposable plastic cell culture bag as it is placed onto a rocking platform in a laboratory at Dutch biotech company uniQure in Amsterdam December 13, 2012.

Tags: big boy drug therapy

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
06.10Atlantic Tropical Weather Outlook
06.10Tropical Storm Milton Graphics
06.10Tropical Storm Milton Public Advisory Number 3A
06.10Summary for Tropical Storm Milton (AT4/AL142024)
06.10Eastern North Pacific Tropical Weather Outlook
06.10Hurricane Leslie Graphics
06.10Hurricane Kirk Graphics
06.10Hurricane Leslie Forecast Discussion Number 15
More »